



	Questions : Lok Sabha




























Screen Reader Access
Skip to Main Content
Skip to Navigation



Text Size

                                A

                                A
A















हिन्दी मे








Parliament of India Lok Sabha House of the
                        People






* Special Characters not allowed












India Time 


Your Time 


                        Monday,
                        11 April 2022









HomeMembersSitting MembersMembers Home PageMembers' PortalContact DetailsMembers SearchStatistical AnalysisAttendance of MembersHandbook Members Since 1952Digitized Who's WhoOthers BusinessProvisional CalendarList of BusinessPapers to be LaidList of Private Members' BusinessBulletin-IDigitized Lok Sabha Bulletin Part IBulletin-IIStatement of WorkSpecial Mentions (ZERO HOUR)Resume of WorkDigitized Resume of Work done by Lok Sabha QuestionsHomeQuestion ListStatus of notices of questionQuestions CalendarGrouping of Ministries - AlphabeticalOfficers in Min./Dept. Dealing with Parliamentary WorkQuestion SearchSupplementary Questions DebatesIntroductionSynopsisUncorrected DebateText of DebateDigitized DebatesConstituent Assembly DebatesWit And HumourDebate SearchHindi FontsDisclaimer Papers LaidPapers Laid on the Table of the House LegislationIntroduction(How Bill Becomes Act)Bills IntroducedBills PassedBills PendingBills AssentedBills LapsedBills WithdrawnBills NegativedBills Search Disclaimer CommitteesIntroductionChairpersonSummary of WorkCommittee Meetings ScheduleBills Referred to CommitteesReports PresentedDigitized ReportsPress ReleaseMembership SearchToday's Committee MeetingsCommittee Subject SelectedDepartment Related-RS Govt. AssurancesSANSAD TVIntranet





HomeQuestion ListStatus of notices of questionQuestions CalendarGrouping of Ministries - AlphabeticalOfficers in Min./Dept. Dealing with Parliamentary WorkQuestion SearchSupplementary Questions











Download as PDF




Print












PDF/WORD(Hindi)


PDF/WORD




                                    GOVERNMENT OF INDIA
                                





                                    MINISTRY OF
                                    HEALTH AND FAMILY WELFARE






                                    LOK SABHA
                                





UNSTARRED 


                                    QUESTION NO:
                                

931






                                    ANSWERED ON: 
                                

18.09.2020






Development of COVID Vaccine




Bidyut Baran Mahato













                                                    Sunil Baburao Mendhe
                                                








                                                    Sanjay Sadashivrao Mandlik
                                                








                                                    Doddaalahalli Kempegowda Suresh
                                                








                                                    Adoor Prakash
                                                








                                                    Thomas Chazhikadan
                                                








                                                    Malook Nagar
                                                








                                                    Shrirang Appa Barne
                                                








                                                    Subhash Chandra Baheria
                                                








                                                    Chandra Sekhar Sahu
                                                








                                                    Mala Rajya Laxmi Shah
                                                








                                                    Sudheer Gupta
                                                








                                                    Pritam Gopinath Munde
                                                








                                                    Ramdas Chandrabhanji Tadas
                                                








                                                    Krupal Balaji Tumane
                                                








                                                    Jagdambika Pal 
                                                












                        Will the Minister of





HEALTH AND FAMILY WELFARE


                        be pleased to state:-















                                                    Will the Minister of HEALTH AND FAMILY WELFARE be pleased to state:(a) the total number of persons affected due to COVID-19 pandemic till date, State/UT-wise;(b) the number of deaths/recoveries reported as on date;(c) the details of Government institutes and private companies which are conducting research on development of COVID-19 vaccines along with the funds allocated/expenditure incurred by the Government in this regard;(d) the status of each vaccine along with the time by which the vaccine is likely to be developed and made available for public and the authority which is likely to determine the price of the vaccine;(e) whether the Government is taking steps to collaborate with international organizations or other countries in the development of vaccine, if so, the details thereof; and(f) whether the Government proposes to establish dedicated research centres for research and development of antidote to epidemic causing pathogens, if so, the details thereof along with other steps taken to curb the increasing proliferation of Corona virus?






ANSWER




                                                        ANSWERTHE MINISTER OF STATE IN THE MINISTRY OF HEALTH AND FAMILY WELFARE(SHRI ASHWINI KUMAR CHOUBEY)(a) & (b):	The State-wise details of total number of active cases, cured/discharged/recovered cases and deaths is an Annexure I. (c):	Nearly 30 vaccine candidates based on multiple technologies / platforms are under development in India, by both academia and industry. The Department of Biotechnology is supporting 8 proposals by industry and 2 proposals by academia for candidate vaccine development and associated research resources. Some major industry based efforts being supported by DBT include Some major projects being supported include Phase III trial of rBCG vaccine by Serum Institute of India, development of mRNA vaccine (Gennova Biopharmaceuticals Ltd.), inactivated rabies virus vector vaccine (Bharat Biotech) and VesiculoVax platform based candidate (Aurobindo Pharma). The funds allocated for these projects by Department of Biotechnology and Department of Science and Technology is approximately Rs. 78.4306 crore.(d):	The vaccines are in different stages of pre-clinical and clinical development. Nearly 3 candidates are in advanced stage of Phase I/II/III trials and 4 are in advanced pre-clinical development stage. Vaccine availability is subject to successful completion of phase III clinical trial.(e):	The Government of India conveyed its intent to be part of the Vaccine Pillar of the Access to COVID-19 Tools (ACT) Accelerator, which may be beneficial in providing access to the global vaccine candidates in advanced stages, for their further utilization in the country. Further, the Department of Biotechnology through the Ind-CEPI Mission is involved in key partnerships with Coalition for Epidemic Preparedness Innovations (CEPI) for supporting Indian researchers for development of clinical immune assays to advance vaccine research. Also, oversight is being provided by the Candidate Vaccine Advisory Committee (CVAC) under the Indo-US Vaccine Action Programme (VAP) to strengthen indigenous vaccine development activities.(f):	Five COVID19 Biorepositories have been setup by Department of Biotechnology, which have collected more than 40,000 samples which have been made available to researchers and industry for developing diagnostics, therapeutics and vaccines. Genome sequencing of more than 2000 SARS-CoV-2 samples collected from across the country has been completed, which is important for development diagnostics, drugs and vaccines.A brief on Public Health Response to COVID-19 is attached as Annexure II. 
























HomeArchiveIndex to Select Questions (1984-1999)Ballot ListStatistical Statements Relating to QuestionsUploading of Questions - Status QueryProcedure for Sending Text of Questions & AnswersDemarcation of responsibilities in Govt. of IndiaBrochure on Statutory Corporations, Companies and Other Bodies in Which the Government of India have financial or controlling interestHighlights pertaining to questions of 17th Lok Sabha






Contact Us 
Disclaimer











        Developed and Hosted by National Informatics Centre (NIC)

Content on this website is published,
            managed & maintained by Software Unit, Computer (HW & SW) Management. Branch,
            Lok Sabha Secretariat





HomeMembersBusinessQuestionsDebatesPapers Laid


LegislationCommitteesSANSAD TVIntranetSecretariatPRIDE


RecruitmentSC/ST ReservationConferenceParliament Library


About ParliamentPhoto GalleryRelated LinksRTITendersFAQ


SpeakerDy. SpeakerLeader of the HousePanel of ChairpersonsContact UsFeedback


Council of MinistersPublications of MinistriesParliamentry ProceduresJournal of Parliamentary Information
Visitor's Counter:113191693







Copyright
Privacy Policy
Disclaimer
Terms &
                Conditions

                Accessibility Statement
Accessibility
                Options
Feedback
Site Map







